Transdermal and Intradermal Drug Delivery Systems
Transdermal Drug Delivery system is a part of drug delivery system and involves more research. Drugs having long pharmacokinetic half-lives are considered to be unfit for transdermal application. By the increased number of marketing authorization applications along with recent scientific developments for transdermal patches, the need for clear guidance and reserach on specific requirements for this dosage form increased.
The emergence of technological innovations in transdermal patches is expected to provide the market with advances growth opportunities over the coming years. Transdermal Drug Delivery system was valued at $32,516 million in 2016, and is estimated to reach $61,689 million by 2023, growing at a CAGR of 9.5%.